Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure

NCT05236673 COMPLETED

The primary objective of this study is to monitor the safety profile of Jardiance® in Korean patient with chronic heart failure (New York Heart Association (NYHA) class II-IV) in a routine clinical setting.

Details

Lead sponsor	Boehringer Ingelheim
Status	COMPLETED
Enrolment	610
Start date	Thu Jul 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Apr 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Heart Failure

Interventions

• JARDIANCE®

Countries

South Korea